GLP-1 agonists are widely used in the treatment of type 2 diabetes mellitus (T2DM) by enhancing insulin response and reducing postprandial glucose levels
doi: 10.1038/nrendo.2011.183 3 ZinmanBWannerCLachinJMFitchettDBluhmkiEHantelSet al
Read Meet with a nurse Youll meet with a nurse before surgery
Atypical anorexia nervosa Patients with atypical anorexia nervosa, a subtype of other specified feeding and eating disorder (OSFED), meet all criteria for anorexia nervosa except that, despite significant weight loss, their weight remains within or above the normal range (American Psychiatric Association, 2013)
[DOI] [PMC free article] [PubMed] [Google Scholar] (414).Canals D
The objective of this review is to critically assess the current evidence surrounding their mechanisms of action, clinical indications, efficacy, and safety profiles, with particular emphasis on regulatory and translational considerations